We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+4.76%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.78B
AUM Growth
-$2.15B
Cap. Flow
-$2.29B
Cap. Flow %
-60.64%
Top 10 Hldgs %
32.15%
Holding
6,174
New
508
Increased
1,418
Reduced
3,468
Closed
480

Top Buys

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$269M
2
SMCI icon
Super Micro Computer
SMCI
+$220M
3
SPXL icon
Direxion Daily S&P 500 Bull 3x ETF
SPXL
+$68M
4
IWM icon
iShares Russell 2000 ETF
IWM
+$61M
5
IVV icon
iShares Core S&P 500 ETF
IVV
+$33.5M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$215M
2
MSFT icon
Microsoft
MSFT
+$203M
3
NVDA icon
NVIDIA
NVDA
+$156M
4
AMZN icon
Amazon
AMZN
+$119M
5
META icon
Meta Platforms (Facebook)
META
+$97.9M

Sector Composition

Rank Sector Weight
1 Technology 21.67%
2 Financials 9.06%
3 Consumer Discretionary 7.38%
4 Healthcare 7.08%
5 Industrials 6.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HMNF
4576
DELISTED
HMN Financial Inc
HMNF
$4.35K ﹤0.01%
156
-665
-81% -$17K
CELZ icon
4577
Creative Medical Technology
CELZ
$8.04M
$4.35K ﹤0.01%
1,403
-696
-33% -$2.36K
TELA icon
4578
TELA Bio
TELA
$35.4M
$4.34K ﹤0.01%
1,717
-6,000
-78% -$21.3K
VERO
4579
DELISTED
Venus Concept
VERO
$4.34K ﹤0.01%
647
-58
-8% -$392
DSS icon
4580
DSS Inc
DSS
$5.15M
$4.34K ﹤0.01%
3,419
-1,534
-31% -$2.19K
VVOS icon
4581
Vivos Therapeutics
VVOS
$4.37M
$4.34K ﹤0.01%
1,663
-620
-27% -$1.62K
BIAF icon
4582
bioAffinity Technologies
BIAF
$3.05M
$4.34K ﹤0.01%
70
-84
-55% -$5.03K
PW
4583
Power REIT
PW
$2.94M
$4.33K ﹤0.01%
575
+95
+20% +$1.14K
PHX
4584
DELISTED
PHX Minerals
PHX
$4.33K ﹤0.01%
1,282
-1,906
-60% -$6.34K
ATXI
4585
DELISTED
Avenue Therapeutics, Inc. Common Stock
ATXI
$4.33K ﹤0.01%
1,740
-1,465
-46% -$4.2K
SDOT icon
4586
Sadot Group
SDOT
$12.9M
$4.33K ﹤0.01%
5
-9
-64% -$7.88K
RDNW
4587
RideNow Group
RDNW
$251M
$4.33K ﹤0.01%
+903
New +$3.73K
SPRU icon
4588
Spruce Power Holding Corp
SPRU
$38.4M
$4.32K ﹤0.01%
1,522
-693
-31% -$2.12K
LARK icon
4589
Landmark Bancorp
LARK
$196M
$4.32K ﹤0.01%
236
-514
-69% -$9.36K
RNXT icon
4590
RenovoRx
RNXT
$51.9M
$4.31K ﹤0.01%
4,070
-3,319
-45% -$3.72K
OPBK icon
4591
OP Bancorp
OPBK
$234M
$4.31K ﹤0.01%
345
-2,295
-87% -$27.2K
QNCX icon
4592
Quince Therapeutics
QNCX
$33.3M
$4.31K ﹤0.01%
28
-20
-42% -$2.87K
NMTC icon
4593
NeuroOne Medical Technologies
NMTC
$13.9M
$4.3K ﹤0.01%
724
-1,177
-62% -$5.89K
NXPL icon
4594
NextPlat
NXPL
$17.5M
$4.3K ﹤0.01%
305
-343
-53% -$4.12K
BRFH icon
4595
Barfresh Food Group
BRFH
$27.3M
$4.3K ﹤0.01%
1,478
-411
-22% -$1.42K
DERM icon
4596
Journey Medical
DERM
$174M
$4.3K ﹤0.01%
761
-4,172
-85% -$21.5K
AVBP icon
4597
ArriVent BioPharma
AVBP
$1.46B
$4.3K ﹤0.01%
183
-1,309
-88% -$29.7K
NRXP icon
4598
NRX Pharmaceuticals
NRXP
$146M
$4.3K ﹤0.01%
2,544
-783
-24% -$1.58K
KALA icon
4599
KALA BIO
KALA
$16.3M
$4.3K ﹤0.01%
15
-22
-59% -$6.94K
GVP
4600
DELISTED
GSE Systems, Inc.
GVP
$4.3K ﹤0.01%
1,056
+157
+17% +$595
182 183
184
185 186

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
BHC
Bowen Hanes & Co Ponte Vedra Beach, Florida $4.11B AUM 41.61% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return

Tower Research Capital (TRC)'s Q3 2024 Portfolio in Review

As of Q3 2024, Tower Research Capital (TRC) held 6,174 positions worth $3.78B, down 36% from $5.92B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Tower Research Capital (TRC) withdrew a net $2.29B in Q3 2024, closing 480 positions and reducing 3,468 holdings. Its most notable exit was iShares Russell 2000 Growth ETF, an estimated $9.26M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 29% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares US Technology ETF worth $6.83M.

  • Tower Research Capital (TRC)'s largest Q3 2024 buy was iShares US Technology ETF: 45,025 shares worth $6.83M.
  • Tower Research Capital (TRC) added most to Invesco QQQ Trust in Q3 2024, an estimated $269M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2024 reduction was Apple, cutting an estimated $215M.
  • Tower Research Capital (TRC) fully exited iShares Russell 2000 Growth ETF in Q3 2024, selling an estimated $9.26M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 32% of its $3.78B portfolio in Q3 2024.
  • Tower Research Capital (TRC) opened 508 new positions and closed 480 in Q3 2024.
  • Tower Research Capital (TRC)'s portfolio value fell 36% quarter-over-quarter to $3.78B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2024, filed 14 Nov 2024.